| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Christine Lochner, Samuel R Chamberlain, Martin Kidd, Lian Taljaard, Naomi A Fineberg, Trevor W Robbins, Dan J Stei. The effects of acute serotonin challenge on executive planning in patients with obsessive-compulsive disorder (OCD), their first-degree relatives, and healthy controls. Psychopharmacology. vol 237. issue 10. 2021-01-12. PMID:32638035. |
obsessive-compulsive disorder (ocd) is characterized by executive function impairment and by clinical responsivity to selective serotonin reuptake inhibitors (ssris). |
2021-01-12 |
2023-08-13 |
Not clear |
| Mehdi Zemestani, Mojgan Salavati, Asrin Seyedolshohadayi, Julie M Petersen, Clarissa W Ong, Michael P Twohig, Ebrahim Ghader. A Preliminary Examination of Acceptance and Commitment Therapy Versus Exposure and Response Prevention for Patients with Obsessive-Compulsive Disorder on an Optimal Dose of SSRIs: A Randomized Controlled Trial in Iran. Behavior modification. 2020-12-28. PMID:33356487. |
this study compared the effects of adding acceptance and commitment therapy (act) or exposure and response prevention (erp) to adults diagnosed with obsessive compulsive disorder (ocd) already on an optimal and stable dose of selective serotonin reuptake inhibitors (ssris). |
2020-12-28 |
2023-08-13 |
Not clear |
| Ali Talaei, Farhad Farid Hosseini, Zahra Aghili, Shahin Akhondzadeh, Elham Asadpour, Neema John Mehramiz, Fatemeh Forouzanfa. A comparative, single-blind, randomized study on quetiapine and aripiperazole augmentation in treatment of selective serotonin reuptake inhibitor refractory obsessive-compulsive disorder. Canadian journal of physiology and pharmacology. vol 98. issue 4. 2020-11-20. PMID:32228235. |
a comparative, single-blind, randomized study on quetiapine and aripiperazole augmentation in treatment of selective serotonin reuptake inhibitor refractory obsessive-compulsive disorder. |
2020-11-20 |
2023-08-13 |
Not clear |
| Melania Cârcu-Dobrin, Monica Budău, Gabriel Hancu, Laszlo Gagyi, Aura Rusu, Hajnal Keleme. Enantioselective analysis of fluoxetine in pharmaceutical formulations by capillary zone electrophoresis. Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society. vol 25. issue 3. 2020-10-01. PMID:28344495. |
fluoxetine is an antidepressant, a selective serotonin reuptake inhibitor (ssri) used primarily in the treatment of major depression, panic disorder and obsessive compulsive disorder. |
2020-10-01 |
2023-08-13 |
Not clear |
| Anna Järvinen, Merja K Laine, Roope Tikkanen, Maija L Castré. Beneficial Effects of GLP-1 Agonist in a Male With Compulsive Food-Related Behavior Associated With Autism. Frontiers in psychiatry. vol 10. 2020-10-01. PMID:30881319. |
these behaviors have similarities to compulsions and/or obsessions in obsessive compulsive disorder (ocd) and are primarily treated with behaviourally-based interventions and serotonin uptake inhibitors (ssris). |
2020-10-01 |
2023-08-13 |
Not clear |
| Kai Zhang, Xiwang Fan, Jianmin Yuan, Jiajun Yin, Hang Su, Kenji Hashimoto, Guoqiang Wan. Impact of serotonin transporter gene on rTMS augmentation of SSRIs for obsessive compulsive disorder. Neuropsychiatric disease and treatment. vol 15. 2020-10-01. PMID:31308670. |
impact of serotonin transporter gene on rtms augmentation of ssris for obsessive compulsive disorder. |
2020-10-01 |
2023-08-13 |
Not clear |
| Narendra Nath Samantaray, Suprakash Chaudhury, Preeti Sing. Efficacy of inhibitory learning theory-based exposure and response prevention and selective serotonin reuptake inhibitor in obsessive-compulsive disorder management: A treatment comparison. Industrial psychiatry journal. vol 27. issue 1. 2020-09-30. PMID:30416292. |
efficacy of inhibitory learning theory-based exposure and response prevention and selective serotonin reuptake inhibitor in obsessive-compulsive disorder management: a treatment comparison. |
2020-09-30 |
2023-08-13 |
Not clear |
| Michelle M Rodriguez, Carl Overshiner, J David Leander, Xia Li, Denise Morrow, Richard G Conway, David L Nelson, Karin Briner, Jeffrey M Witki. Behavioral Effects of a Novel Benzofuranyl-Piperazine Serotonin-2C Receptor Agonist Suggest a Potential Therapeutic Application in the Treatment of Obsessive-Compulsive Disorder. Frontiers in psychiatry. vol 8. 2020-09-29. PMID:28588509. |
selective serotonin reuptake inhibitors (ssris) are the only effective pharmacological treatments for obsessive-compulsive disorder (ocd). |
2020-09-29 |
2023-08-13 |
Not clear |
| Vijaya Padma Kotapati, Ali M Khan, Sara Dar, Gulshan Begum, Ramya Bachu, Mahwish Adnan, Aarij Zubair, Rizwan A Ahme. The Effectiveness of Selective Serotonin Reuptake Inhibitors for Treatment of Obsessive-Compulsive Disorder in Adolescents and Children: A Systematic Review and Meta-Analysis. Frontiers in psychiatry. vol 10. 2020-09-29. PMID:31447707. |
the effectiveness of selective serotonin reuptake inhibitors for treatment of obsessive-compulsive disorder in adolescents and children: a systematic review and meta-analysis. |
2020-09-29 |
2023-08-13 |
Not clear |
| Murad Atmac. Selective Serotonin Reuptake Inhibitor-Induced Sexual Dysfunction: Current Management Perspectives. Neuropsychiatric disease and treatment. vol 16. 2020-09-28. PMID:32368066. |
selective serotonin reuptake inhibitors (ssris) are a widely used class of drugs which are prescribed for the treatment of a variety of disorders, including major depressive disorder, obsessive-compulsive disorder, posttraumatic stress disorder, panic disorder, generalized anxiety disorder, and impulse control disorders. |
2020-09-28 |
2023-08-13 |
Not clear |
| Mohsen Dadashi, Vida Yousefi Asl, Yousef Morsal. Cognitive-Behavioral Therapy Versus Transcranial Direct Current Stimulation for Augmenting Selective Serotonin Reuptake Inhibitors in Obsessive-Compulsive Disorder Patients. Basic and clinical neuroscience. vol 11. issue 1. 2020-09-28. PMID:32483481. |
cognitive-behavioral therapy versus transcranial direct current stimulation for augmenting selective serotonin reuptake inhibitors in obsessive-compulsive disorder patients. |
2020-09-28 |
2023-08-13 |
Not clear |
| Meagan A Quinlan, Matthew J Robson, Ran Ye, Kristie L Rose, Kevin L Schey, Randy D Blakel. Frontiers in molecular neuroscience. vol 13. 2020-09-28. PMID:32581705. |
altered serotonin (5-ht) signaling is associated with multiple brain disorders, including major depressive disorder (mdd), obsessive-compulsive disorder (ocd), and autism spectrum disorder (asd). |
2020-09-28 |
2023-08-13 |
human |
| K R Müller-Vahl, N Szejko, F Wilke, E Jakubovski, L Geworski, F Bengel, G Berdin. Author Correction: Serotonin transporter binding is increased in Tourette syndrome with Obsessive Compulsive Disorder. Scientific reports. vol 10. issue 1. 2020-09-17. PMID:32606446. |
author correction: serotonin transporter binding is increased in tourette syndrome with obsessive compulsive disorder. |
2020-09-17 |
2023-08-13 |
Not clear |
| Joseph Strayhor. Editorial: Cognitive-Behavioral Therapy Versus Serotonin Reuptake Inhibitors for Pediatric Obsessive-Compulsive Disorder. Journal of the American Academy of Child and Adolescent Psychiatry. vol 59. issue 2. 2020-09-15. PMID:30904480. |
editorial: cognitive-behavioral therapy versus serotonin reuptake inhibitors for pediatric obsessive-compulsive disorder. |
2020-09-15 |
2023-08-13 |
Not clear |
| Meredith E Coles, Matthew H Goodma. A systematic review of case studies testing a melatonergic agonist/ 5HT Journal of anxiety disorders. vol 69. 2020-09-14. PMID:31877423. |
a systematic review of case studies testing a melatonergic agonist/ 5ht treatments for obsessive-compulsive disorder (ocd) have greatly improved over time. |
2020-09-14 |
2023-08-13 |
Not clear |
| Georgina Krebs, Isobel Heyma. Treatment-resistant Obsessive-compulsive Disorder in Young People: Assessment and Treatment Strategies. Child and adolescent mental health. vol 15. issue 1. 2020-08-27. PMID:32847213. |
cognitive behaviour therapy (cbt) and selective serotonin reuptake inhibitors have both been established as effective interventions for paediatric obsessive-compulsive disorder (ocd), with cbt being the recommended first-line treatment in most cases. |
2020-08-27 |
2023-08-13 |
Not clear |
| K R Müller-Vahl, N Szejko, F Wilke, E Jakubovski, L Geworski, F Bengel, G Berdin. Serotonin transporter binding is increased in Tourette syndrome with Obsessive Compulsive Disorder. Scientific reports. vol 9. issue 1. 2020-08-10. PMID:30700759. |
serotonin transporter binding is increased in tourette syndrome with obsessive compulsive disorder. |
2020-08-10 |
2023-08-13 |
Not clear |
| Andrea Stachon, Isabela Machado da Silv. Dissemination of Evidence-Based Treatment for Pediatric Obsessive-Compulsive Disorder in the Southern Region of Brazil: Challenges and Future Directions. Journal of cognitive psychotherapy. vol 28. issue 3. 2020-08-07. PMID:32759156. |
pediatric obsessive-compulsive disorder (ocd) is a prevalent condition that responds well to specialized treatment including cognitive behavioral therapy (cbt) or serotonin reuptake inhibitors or their combination. |
2020-08-07 |
2023-08-13 |
Not clear |
| Minah Kim, Seoyeon Kwak, Youngwoo Bryan Yoon, Yoo Bin Kwak, Taekwan Kim, Kang Ik K Cho, Tae Young Lee, Jun Soo Kwo. Functional connectivity of the raphe nucleus as a predictor of the response to selective serotonin reuptake inhibitors in obsessive-compulsive disorder. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. vol 44. issue 12. 2020-07-10. PMID:31189178. |
functional connectivity of the raphe nucleus as a predictor of the response to selective serotonin reuptake inhibitors in obsessive-compulsive disorder. |
2020-07-10 |
2023-08-13 |
human |
| Minah Kim, Seoyeon Kwak, Youngwoo Bryan Yoon, Yoo Bin Kwak, Taekwan Kim, Kang Ik K Cho, Tae Young Lee, Jun Soo Kwo. Functional connectivity of the raphe nucleus as a predictor of the response to selective serotonin reuptake inhibitors in obsessive-compulsive disorder. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. vol 44. issue 12. 2020-07-10. PMID:31189178. |
selective serotonin reuptake inhibitors (ssris) are first-line pharmacological agents for treating obsessive-compulsive disorder (ocd). |
2020-07-10 |
2023-08-13 |
human |